Greenleaf Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-629
| Closed | -$207K | – | 802 |
|
|
2024
Q4 | $207K | Buy |
629
+26
| +4% | +$8.54K | ﹤0.01% | 773 |
|
|
2024
Q3 | $202K | Buy |
+603
| New | +$202K | ﹤0.01% | 801 |
|
|
2024
Q2 | – | Sell |
-682
| Closed | -$236K | – | 799 |
|
|
2024
Q1 | $236K | Sell |
682
-13
| -2% | -$4.5K | ﹤0.01% | 692 |
|
|
2023
Q4 | $224K | Buy |
+695
| New | +$224K | ﹤0.01% | 688 |
|
|
2023
Q3 | – | Sell |
-551
| Closed | -$209K | – | 748 |
|
|
2023
Q2 | $209K | Buy |
551
+40
| +8% | +$15.2K | ﹤0.01% | 715 |
|
|
2023
Q1 | $245K | Buy |
+511
| New | +$245K | ﹤0.01% | 667 |
|
|
2022
Q3 | – | Sell |
-421
| Closed | -$208K | – | 716 |
|
|
2022
Q2 | $208K | Sell |
421
-23
| -5% | -$11.4K | ﹤0.01% | 666 |
|
|
2022
Q1 | $250K | Sell |
444
-18
| -4% | -$10.1K | ﹤0.01% | 651 |
|
|
2021
Q4 | $349K | Buy |
462
+33
| +8% | +$24.9K | ﹤0.01% | 549 |
|
|
2021
Q3 | $320K | Buy |
429
+18
| +4% | +$13.4K | ﹤0.01% | 552 |
|
|
2021
Q2 | $265K | Buy |
411
+5
| +1% | +$3.22K | ﹤0.01% | 619 |
|
|
2021
Q1 | $232K | Buy |
406
+20
| +5% | +$11.4K | ﹤0.01% | 642 |
|
|
2020
Q4 | $225K | Buy |
+386
| New | +$225K | ﹤0.01% | 565 |
|